Search Results - "Bondarov, P."

Esomeprazole 40 mg i.v. provides faster and more effective intragastric acid control than pantoprazole 40 mg i.v.: results of a randomized study by Wilder‐Smith, C. H., Röhss, K., Bondarov, P., Hallerbäck, B., Svedberg, L.‐E., Ahlbom, H.

“…Summary Background : Oral esomeprazole 40 mg provides greater acid control than oral pantoprazole 40 mg. Aim : To compare the effects on intragastric acid…”
Get full text

Intravenous esomeprazole (40 mg and 20 mg) inhibits gastric acid secretion as effectively as oral esomeprazole: results of two randomized clinical studies by Wilder-Smith, Clive H, Bondarov, Patrik, Lundgren, Marie, Niazi, Mohammad, Röhss, Kerstin, Ahlbom, Henrik, Nyman, Lars

“…OBJECTIVESTwo studies compared the effects of intravenous (i.v.) and oral esomeprazole (40 mg and 20 mg) on gastric acid suppression and pharmacokinetics after…”
Get full text

Pharmacokinetics and Acid‐suppressive Effects of Esomeprazole in Infants 1–24 Months Old With Symptoms of Gastroesophageal Reflux Disease by Omari, Taher, Davidson, Geoffrey, Bondarov, Patrik, Nauclér, Emma, Nilsson, Catarina, Lundborg, Per

“…ABSTRACT Objectives: To evaluate the pharmacokinetics and acid‐suppressive effects of esomeprazole in infants with gastroesophageal reflux disease (GERD)…”
Get full text

Pharmacological cardioversion of atrial fibrillation-a double-blind, randomized, placebo-controlled, multicentre, dose-escalation study of AZD1305 given intravenously by Rónaszéki, Aladár, Alings, Marco, Egstrup, Kenneth, Gaciong, Zbigniew, Hranai, Marián, Király, Csaba, Sereg, Matyas, Figatowski, Włodzimierz, Bondarov, Patrik, Johansson, Susanne, Frison, Lars, Edvardsson, Nils, Berggren, Anders

“…Aim AZD1305 is a combined ion channel blocker developed for the treatment of atrial fibrillation (AF). The aim of this study was to determine whether AZD1305…”
Get full text

THE EFFECT OF REPEATED DOSES OF ESOMEPRAZOLE ON PHARMACODYNAMIC AND PHARMACOKINETIC VARIABLES IN INFANTS AGED 1 TO 24 MONTHS WITH GERD by Omari, T, Davidson, G, Bondarov, P, Naucler, E, Nilsson, C, Lundborg, P

Get full text

Esomeprazole 40 mg intravenous provides faster and more effective acid control than pantoprazole 40 mg intravenous after first dose and 5 days by Wilder-Smith∗, C., Bondarov, P., Hallerbäck, B., Nilsson-Pieschl, C., Ahlbom, H., Röhss, K.

Get full text

Esomeprazole 40 mg intravenous provides faster and more effective acid control than pantoprazole 40 mg intravenous after first dose and 5 days by Wilder-smith, C, Bondarov, P, Hallerbäck, B, Nilsson-pieschl, C, Ahlbom, H, Röhss, K

Get full text

Pharmacokinetics of Esomeprazole Following Varying Intravenous Administration Rates by Niazi, Mohammad, Ahlbom, Henrik, Bondarov, Patrik, Karlsson, Anna H., Hassan‐Alin, Mohammed, Rydholm, Hans, Röhss, Kerstin

“…: There are situations where the use of an oral proton pump inhibitors is not possible. In such situations an intravenous route is the preferred alternative…”
Get full text

Intravenous Esomeprazole 40mg is Effective for the Control of Intragastric Acid Levels Whether Given as a 3-Minute Injection or a 30-Minute Infusion by Wilder-Smith, Clive, Röhss, Kerstin, Bondarov, Patrik, Hassan-Alin, Mohammed, Lundin, Christina, Niazi, Mohammad, Nilsson-Pieschl, Catharina, Ahlbom, Henrik

“…An intravenous (IV) formulation of esomeprazole has been developed as an alternative to oral administration. To meet the needs of different clinical situations…”
Get full text

ESOMEPRAZOLE 40 MG INTRAVENOUS PROVIDES FASTER AND MORE EFFECTIVE ACID CONTROL THAN PANTOPRAZOLE 40 MG INTRAVENOUS AFTER FIRST DOSE AND 5 DAYS: 70 by Wilder-Smith, C., Bondarov, P., Hallerbäck, B., Nilsson-Pieschl, C., Ahlbom, H., Röhss, K.

Get full text